Advertisement

Index by author

October 01, 1991; Volume 40,Issue 4

A

  1. Adachi, K

    1. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
      J E Andrea, K Adachi and A R Morgan
      Molecular Pharmacology October 1991, 40 (4) 495-501;

  2. Adelman, J P

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

  3. Akman, S

    1. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity.
      G L Forrest, S Akman, J Doroshow, H Rivera and W D Kaplan
      Molecular Pharmacology October 1991, 40 (4) 502-507;

  4. Aktories, K

    1. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
      F Grimminger, U Sibelius, K Aktories, N Suttorp and W Seeger
      Molecular Pharmacology October 1991, 40 (4) 563-571;

  5. Ali, H

    1. GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
      M Hide, H Ali, S R Price, J Moss and M A Beaven
      Molecular Pharmacology October 1991, 40 (4) 473-479;

  6. Anderson, R S

    1. 2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.
      Y H Ling, J A Nelson, Y C Cheng, R S Anderson and K L Beattie
      Molecular Pharmacology October 1991, 40 (4) 508-514;

  7. Andrea, J E

    1. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
      J E Andrea, K Adachi and A R Morgan
      Molecular Pharmacology October 1991, 40 (4) 495-501;

  8. Atkinson, B

    1. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor-mediated second messenger responses in rat brain.
      K P Minneman and B Atkinson
      Molecular Pharmacology October 1991, 40 (4) 523-530;

B

  1. Beattie, K L

    1. 2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.
      Y H Ling, J A Nelson, Y C Cheng, R S Anderson and K L Beattie
      Molecular Pharmacology October 1991, 40 (4) 508-514;

  2. Beaven, M A

    1. GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
      M Hide, H Ali, S R Price, J Moss and M A Beaven
      Molecular Pharmacology October 1991, 40 (4) 473-479;

  3. Bernard, B A

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  4. Birnbaumer, M

    1. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
      J A Johnson, J Friedman, R D Halligan, M Birnbaumer and R B Clark
      Molecular Pharmacology October 1991, 40 (4) 539-546;

  5. Boynton, A L

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;

  6. Brann, M R

    1. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
      F Dörje, A I Levey and M R Brann
      Molecular Pharmacology October 1991, 40 (4) 459-462;

  7. Busch, A E

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

C

  1. Cabantchik, Z I

    1. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
      S D Lytton, Z I Cabantchik, J Libman and A Shanzer
      Molecular Pharmacology October 1991, 40 (4) 584-590;

  2. Cavey, M T

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  3. Cheng, Y C

    1. 2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.
      Y H Ling, J A Nelson, Y C Cheng, R S Anderson and K L Beattie
      Molecular Pharmacology October 1991, 40 (4) 508-514;

  4. Cianci, C W

    1. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
      B J Terry, C W Cianci and M E Hagen
      Molecular Pharmacology October 1991, 40 (4) 591-596;

  5. Clark, R B

    1. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
      J A Johnson, J Friedman, R D Halligan, M Birnbaumer and R B Clark
      Molecular Pharmacology October 1991, 40 (4) 539-546;

D

  1. Darmon, M

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  2. Delescluse, C

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  3. Dörje, F

    1. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
      F Dörje, A I Levey and M R Brann
      Molecular Pharmacology October 1991, 40 (4) 459-462;

  4. Doroshow, J

    1. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity.
      G L Forrest, S Akman, J Doroshow, H Rivera and W D Kaplan
      Molecular Pharmacology October 1991, 40 (4) 502-507;

  5. Dukelow, M

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;

F

  1. Fenselau, C

    1. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats.
      G B Odell, W S Mogilevsky, P B Smith and C Fenselau
      Molecular Pharmacology October 1991, 40 (4) 597-605;

  2. Forrest, G L

    1. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity.
      G L Forrest, S Akman, J Doroshow, H Rivera and W D Kaplan
      Molecular Pharmacology October 1991, 40 (4) 502-507;

  3. Franklin, S O

    1. Transsynaptic activity regulates proenkephalin and tyrosine hydroxylase gene expression and the response to reserpine in the hamster adrenal.
      S O Franklin, Y S Zhu, B C Yoburn and C E Inturrisi
      Molecular Pharmacology October 1991, 40 (4) 515-522;

  4. Friedman, J

    1. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
      J A Johnson, J Friedman, R D Halligan, M Birnbaumer and R B Clark
      Molecular Pharmacology October 1991, 40 (4) 539-546;

G

  1. Gottesman, M M

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

  2. Grimminger, F

    1. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
      F Grimminger, U Sibelius, K Aktories, N Suttorp and W Seeger
      Molecular Pharmacology October 1991, 40 (4) 563-571;

  3. Guzikowski, A P

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

H

  1. Hagen, M E

    1. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
      B J Terry, C W Cianci and M E Hagen
      Molecular Pharmacology October 1991, 40 (4) 591-596;

  2. Halligan, R D

    1. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
      J A Johnson, J Friedman, R D Halligan, M Birnbaumer and R B Clark
      Molecular Pharmacology October 1991, 40 (4) 539-546;

  3. Han, C D

    1. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor binding sites in rat tissues.
      C D Han and K P Minneman
      Molecular Pharmacology October 1991, 40 (4) 531-538;

  4. Harden, T K

    1. Receptor- and G-protein-regulated 150-kDa avian phospholipase C: inhibition of enzyme activity by isoenzyme-specific antisera and nonidentity with mammalian phospholipase C isoenzymes established by immunoreactivity and peptide sequence.
      G L Waldo, A J Morris, D G Klapper and T K Harden
      Molecular Pharmacology October 1991, 40 (4) 480-489;

  5. Haugland, R P

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

  6. Hide, M

    1. GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
      M Hide, H Ali, S R Price, J Moss and M A Beaven
      Molecular Pharmacology October 1991, 40 (4) 473-479;

  7. Hokin, L E

    1. Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology October 1991, 40 (4) 547-555;

  8. Honkanen, R E

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;

  9. Hurst, R S

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

I

  1. Inturrisi, C E

    1. Transsynaptic activity regulates proenkephalin and tyrosine hydroxylase gene expression and the response to reserpine in the hamster adrenal.
      S O Franklin, Y S Zhu, B C Yoburn and C E Inturrisi
      Molecular Pharmacology October 1991, 40 (4) 515-522;

J

  1. Johnson, J A

    1. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
      J A Johnson, J Friedman, R D Halligan, M Birnbaumer and R B Clark
      Molecular Pharmacology October 1991, 40 (4) 539-546;

K

  1. Kaplan, W D

    1. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity.
      G L Forrest, S Akman, J Doroshow, H Rivera and W D Kaplan
      Molecular Pharmacology October 1991, 40 (4) 502-507;

  2. Kavanaugh, M P

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

  3. Khatra, B S

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;

  4. Klapper, D G

    1. Receptor- and G-protein-regulated 150-kDa avian phospholipase C: inhibition of enzyme activity by isoenzyme-specific antisera and nonidentity with mammalian phospholipase C isoenzymes established by immunoreactivity and peptide sequence.
      G L Waldo, A J Morris, D G Klapper and T K Harden
      Molecular Pharmacology October 1991, 40 (4) 480-489;

L

  1. Lelong, I H

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

  2. Levey, A I

    1. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
      F Dörje, A I Levey and M R Brann
      Molecular Pharmacology October 1991, 40 (4) 459-462;

  3. Libman, J

    1. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
      S D Lytton, Z I Cabantchik, J Libman and A Shanzer
      Molecular Pharmacology October 1991, 40 (4) 584-590;

  4. Lindstrom, J

    1. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
      P Whiting, R Schoepfer, J Lindstrom and T Priestley
      Molecular Pharmacology October 1991, 40 (4) 463-472;

  5. Ling, Y H

    1. 2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.
      Y H Ling, J A Nelson, Y C Cheng, R S Anderson and K L Beattie
      Molecular Pharmacology October 1991, 40 (4) 508-514;

  6. Lytton, S D

    1. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
      S D Lytton, Z I Cabantchik, J Libman and A Shanzer
      Molecular Pharmacology October 1991, 40 (4) 584-590;

M

  1. Maignan, J

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  2. Martin, B

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  3. Minneman, K P

    1. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor-mediated second messenger responses in rat brain.
      K P Minneman and B Atkinson
      Molecular Pharmacology October 1991, 40 (4) 523-530;
    2. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor binding sites in rat tissues.
      C D Han and K P Minneman
      Molecular Pharmacology October 1991, 40 (4) 531-538;

  4. Mogilevsky, W S

    1. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats.
      G B Odell, W S Mogilevsky, P B Smith and C Fenselau
      Molecular Pharmacology October 1991, 40 (4) 597-605;

  5. Moore, R E

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;

  6. Morgan, A R

    1. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
      J E Andrea, K Adachi and A R Morgan
      Molecular Pharmacology October 1991, 40 (4) 495-501;

  7. Morris, A J

    1. Receptor- and G-protein-regulated 150-kDa avian phospholipase C: inhibition of enzyme activity by isoenzyme-specific antisera and nonidentity with mammalian phospholipase C isoenzymes established by immunoreactivity and peptide sequence.
      G L Waldo, A J Morris, D G Klapper and T K Harden
      Molecular Pharmacology October 1991, 40 (4) 480-489;

  8. Moss, J

    1. GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
      M Hide, H Ali, S R Price, J Moss and M A Beaven
      Molecular Pharmacology October 1991, 40 (4) 473-479;

N

  1. Nelson, J A

    1. 2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.
      Y H Ling, J A Nelson, Y C Cheng, R S Anderson and K L Beattie
      Molecular Pharmacology October 1991, 40 (4) 508-514;

  2. Nen, W

    1. Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology October 1991, 40 (4) 547-555;

  3. North, R A

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

O

  1. Odell, G B

    1. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats.
      G B Odell, W S Mogilevsky, P B Smith and C Fenselau
      Molecular Pharmacology October 1991, 40 (4) 597-605;

  2. Osborne, P B

    1. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
      R S Hurst, A E Busch, M P Kavanaugh, P B Osborne, R A North and J P Adelman
      Molecular Pharmacology October 1991, 40 (4) 572-576;

P

  1. Pastan, I

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

  2. Price, S R

    1. GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
      M Hide, H Ali, S R Price, J Moss and M A Beaven
      Molecular Pharmacology October 1991, 40 (4) 473-479;

  3. Priestley, T

    1. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
      P Whiting, R Schoepfer, J Lindstrom and T Priestley
      Molecular Pharmacology October 1991, 40 (4) 463-472;

R

  1. Reichert, U

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  2. Reichman, M

    1. Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology October 1991, 40 (4) 547-555;

  3. Rivera, H

    1. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity.
      G L Forrest, S Akman, J Doroshow, H Rivera and W D Kaplan
      Molecular Pharmacology October 1991, 40 (4) 502-507;

S

  1. Schoepfer, R

    1. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
      P Whiting, R Schoepfer, J Lindstrom and T Priestley
      Molecular Pharmacology October 1991, 40 (4) 463-472;

  2. Seeger, W

    1. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
      F Grimminger, U Sibelius, K Aktories, N Suttorp and W Seeger
      Molecular Pharmacology October 1991, 40 (4) 563-571;

  3. Shanzer, A

    1. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
      S D Lytton, Z I Cabantchik, J Libman and A Shanzer
      Molecular Pharmacology October 1991, 40 (4) 584-590;

  4. Shroot, B

    1. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
      C Delescluse, M T Cavey, B Martin, B A Bernard, U Reichert, J Maignan, M Darmon and B Shroot
      Molecular Pharmacology October 1991, 40 (4) 556-562;

  5. Sibelius, U

    1. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
      F Grimminger, U Sibelius, K Aktories, N Suttorp and W Seeger
      Molecular Pharmacology October 1991, 40 (4) 563-571;

  6. Smith, P B

    1. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats.
      G B Odell, W S Mogilevsky, P B Smith and C Fenselau
      Molecular Pharmacology October 1991, 40 (4) 597-605;

  7. Suttorp, N

    1. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
      F Grimminger, U Sibelius, K Aktories, N Suttorp and W Seeger
      Molecular Pharmacology October 1991, 40 (4) 563-571;

T

  1. Terry, B J

    1. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
      B J Terry, C W Cianci and M E Hagen
      Molecular Pharmacology October 1991, 40 (4) 591-596;

W

  1. Waldo, G L

    1. Receptor- and G-protein-regulated 150-kDa avian phospholipase C: inhibition of enzyme activity by isoenzyme-specific antisera and nonidentity with mammalian phospholipase C isoenzymes established by immunoreactivity and peptide sequence.
      G L Waldo, A J Morris, D G Klapper and T K Harden
      Molecular Pharmacology October 1991, 40 (4) 480-489;

  2. Whiting, P

    1. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
      P Whiting, R Schoepfer, J Lindstrom and T Priestley
      Molecular Pharmacology October 1991, 40 (4) 463-472;

  3. Willingham, M C

    1. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
      I H Lelong, A P Guzikowski, R P Haugland, I Pastan, M M Gottesman and M C Willingham
      Molecular Pharmacology October 1991, 40 (4) 490-494;

Y

  1. Yoburn, B C

    1. Transsynaptic activity regulates proenkephalin and tyrosine hydroxylase gene expression and the response to reserpine in the hamster adrenal.
      S O Franklin, Y S Zhu, B C Yoburn and C E Inturrisi
      Molecular Pharmacology October 1991, 40 (4) 515-522;

Z

  1. Zhu, Y S

    1. Transsynaptic activity regulates proenkephalin and tyrosine hydroxylase gene expression and the response to reserpine in the hamster adrenal.
      S O Franklin, Y S Zhu, B C Yoburn and C E Inturrisi
      Molecular Pharmacology October 1991, 40 (4) 515-522;

  2. Zwiller, J

    1. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.
      R E Honkanen, M Dukelow, J Zwiller, R E Moore, B S Khatra and A L Boynton
      Molecular Pharmacology October 1991, 40 (4) 577-583;
Back to top

In this issue

Advertisement